Estrogen-specific target site identified by Progesterone-11α-hemisuccinate-(2-[125I]-iodohistamine) in mouse brain membranes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 1, 1996, Pages 89-94

  Büküşoǧlu, Cüneyt ^a   Krieger, Neil R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ALDOSTERONE; ANDROSTANEDIOL; ANDROSTERONE; DIETHYLSTILBESTROL; ESTRADIOL; ESTRIOL; ESTROGEN; PROGESTERONE; PROGESTERONE DERIVATIVE; TAMOXIFEN;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CEREBELLUM; CONTROLLED STUDY; HEART; LIVER; MALE; MOUSE; NONHUMAN;

EID: 0030130511     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00017-9     Document Type: Article

References (29)

1. 1. McEwen B. S.: Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12 (1991) 141-147.
2. 2. Wehling M.: Nongenomic actions of steroid hormones. Trends Endocr. Methods 5 (1994) 347-353.
3. 3. Paul S. M. and Purdy R. H.: Neuroactive steroids. FASEB J. 6 (1992) 2311-2322.
4. 4. Nabekura J., Oomura Y., Minami T., Mizuno Y. and Fukuda A.: Mechanism of the rapid effect of 17β-estradiol on medial amygdala neurons. Science 233 (1986) 226-228.
5. 5. Drouva S. V., Laplante E., Gautron J.-P. and Kordon C.: Effects of 17β-estradiol on LH-RH release from rat mediobasal hypothalamic slices. Neuroendocrinology 38 (1984) 152-157.
6. 6. Dufy B., Vincent J.-D., Fleury H., Pasquier P. D., Gourdji D. and Tixier-Vidal A. : Membrane effects of thyrotropin-releasing hormone and estrogen shown by intracellular recording from pituitary cells. Science 204 (1979) 509-511.
7. 7. Morley P., Witfield J. F., Vanderhyden B. C., Tsang B. K. and Schwartz J.-L.: A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131 (1992) 1305-1312.
8. 8. Wu F. S., Gibbs T. T. and Farb D. H.: Inverse modulation of γ-aminobutyric acid and glycine-induced currents by progesterone. Mol. Pharmacol. 37 (1990) 597-602.
9. 9. Schumacher M., Coirini H., Pfaff D. W. and McEwen B. S.: Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors. Science 250 (1990) 691-694.
10. 10. Biegon A. and McEwen B. S.: Modulation by estradiol of serotonin receptors in brain. J. Neurosci. 2 (1982) 199-205.
11. 11. Wahli W. and Martinez E.: Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J. 5 (1991) 2243-2249.
12. 12. Bression D., Michard M., Le Dafniet M., Pagesy P. and Peillon F.: Evidence for a specific estradiol binding site on rat pituitary membranes. Endocrinology 119 (1986) 1048-1051.
13. 13. Towle A. C. and Sze P. Y.: Steroid binding to synaptic plasma membrane: differential binding of glucocorticoids and gonadal steroids. J. Steriod Biochem. 18 (1983) 135-143.
14. 14. Tischkau S. A. and Ramirez V. D.: A specific membrane binding protein for progesterone in rat brain: sex differences and induction by estrogen. Proc. Natn. Acad. Sci. 90 (1993) 1285-1289.
15. 125I] iodohistamine) identifies four protein bands in mouse brain membranes. J. Neurochem. 63 (1994) 1434-1438.
16. 16. Blondeau J. P. and Baulieu E. E.: Progesterone receptor characterized by photoaffinity labeling in the plasma membrane of Xenopus Laevis oocytes. Biochem. J. 219 (1984) 785-792.
17. 17. Qian X. D. and Beck W. T.: Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblats. J. Biol. Chem. 265 (1990) 18753-18756.
18. 125I]-iodohistamine radioligands. J. Steroid Biochem. 6 (1974) 51-56.
19. 19. Peterson G. L.: A simplification of the protein assay method of Lowry et al. Which is more generally applicable?. Analyt. Biochem. 83 (1977) 346-356.
20. 20. Sidmann R. L., Angevine Jr J. B. and Pierce E. T.: Atlas of the mouse brain and spinal cord. Harvard University Press, Cambridge, MA (1971).
21. 21. Kolbe H. V. J. and Wohlrab H.: Mitochondrial phosphate transport. Large scale isolation and characterization of the phosphate transport protein from beef heart mitochondria. J. Biol. Chem. 259 (1984) 9115-9120.
22. 22. Zar J. H.: Biostatistical Analysis. 2nd edn. Prentice-Hall, Inc., Englewood Cliffs, NJ (1984) pp. 122-148.
23. 23. Orchinik M. and Murray T. F.: Steroid hormone binding to membrane receptors. In Methods in Neurosciences Vol. 22 (Edited by E. Ronald de Kloet and Win Sutanto). Academic Press, San Diego, CA pp. 96-115.
24. 24. Ikeda M., Ogata F., Curtis S. W., Lubahn D. B., French F. S., Wilson E. M. and Korach K. S.: Characterization of the DNA-binding domain of the mouse uterine estrogen receptor using site-specific polyclonal antibodies. J. Biol. Chem. 268 (1993) 10296-10302.
25. 25. Bergink E. W.: Oestriol receptor interactions: their biological importance and therapeutic implications. Acta Endocr. Suppl. 233 (1980) 9-16.
26. 26. Trump D. L., Smith D. C., Ellis P. G., Rogers M. P., Schold S. C., Winer E. P., Panella T. J., Jordan V. C. and Fine R. L.: High dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. J. Natl. Cancer Inst. 84 (1992) 1811-1816.
27. 27. Couldwell W. T., Weiss M. H., DeGiorgio C. M., Weiner M. H., Hinton D. P., Ehresmann G. R., Conti P. S. and Apuzzo M. L. J.: Clinical and radiographic response in a minority of patients with recurrent maignant gliomas treated with high-dose tamoxifen. Neurosurgery 32 (1993) 485-490.
28. 28. Korenman S. G.: Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 13 (1969) 163-177.
29. 29. Ojasoo T. and Raynaud J. P.: Unique steroid congeners for receptor studies. Cancer Res. 38 (1978) 4186-4198.